Revaccinated People Report No Concerning Side Effects From Russia’s Sputnik V

© AP Photo / Pavel GolovkinIn this Thursday, Dec. 10, 2020 file photo, a vial with Russia's Sputnik V coronavirus vaccine in a medical room rests on a table prior to a vaccination in Moscow. The South African drug regulator has rejected the Russian-made coronavirus vaccine Sputnik V, citing some safety concerns the manufacturer wasn't able to answer. In a statement on Tuesday, the country's regulator, also known as SAHPRA, said the request for Sputnik V to be authorized could “not be approved at this time,” referring to past failed HIV vaccines that used a similar technology.
In this Thursday, Dec. 10, 2020 file photo, a vial with Russia's Sputnik V coronavirus vaccine in a medical room rests on a table prior to a vaccination in Moscow. The South African drug regulator has rejected the Russian-made coronavirus vaccine Sputnik V, citing some safety concerns the manufacturer wasn't able to answer. In a statement on Tuesday, the country's regulator, also known as SAHPRA, said the request for Sputnik V to be authorized could “not be approved at this time,” referring to past failed HIV vaccines that used a similar technology. - Sputnik International, 1920, 01.11.2021
Subscribe
International
India
Africa
MOSCOW (Sputnik) - There have been no complaints about side effects from the Russian Sputnik V vaccine against COVID-19 even among people who have been revaccinated, Alexander Gintsburg, the head of the Russian Gamaleya research center, told Sputnik.
"There are currently absolutely no complaints about side effects," Gintsburg said, when asked about side effects, particularly among those who have received a third shot of Sputnik V.
In August 2020, Russia became the first country in the world to register a vaccine against the coronavirus, dubbed Sputnik V, and developed by the Gamaleya research institute. So far, the vaccine has been approved for emergency use in over 70 countries.
Moscow is currently carrying out a study of Sputnik V safety and effectiveness for children.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала